← All trials
NCT02202499
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 17, 2014
- Primary completion
- Dec 11, 2015
- Completion date
- Mar 31, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 86
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of South FloridaLead sponsor
- University of South FloridaOverall official - principal investigator
- PfizerCollaborator
- James and Esther King Biomedical Research ProgramCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.